Veterinary Telehealth Market Projected to Reach $10.6 Billion by 2032 Amidst Technological Advancements and Surging Pet Ownership
21 déc. 2023 10h28 HE
|
Research and Markets
Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Veterinary Telehealth Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering. Recent years...
Kane Biotech Receives Offer for its Interest in STEM Animal Health
20 déc. 2023 08h29 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on December 19, 2023, it signed a...
Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis
06 déc. 2023 08h19 HE
|
Gallant Therapeutics
Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis
Kane Biotech Announces Improved Third Quarter 2023 Financial Results
28 nov. 2023 16h05 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2023 financial results. Third...
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
21 nov. 2023 07h45 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Enhancing Animal Welfare: How AI is Reshaping Diagnosis and Treatment in Animal Health
20 nov. 2023 10h53 HE
|
Research and Markets
Dublin, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) In Animal Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been...
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
08 nov. 2023 16h00 HE
|
Dyadic International, Inc.
Received an upfront payment of $0.6 million in October for product development and licensing of our Dapibus™ platform for animal-free dairy enzyme productsDYAI-100 Phase 1 clinical trial top-line...
Dyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
25 oct. 2023 16h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Digital Ally Appoints New Member of the Board of Directors
17 oct. 2023 08h10 HE
|
Digital Ally, Inc.
LENEXA, KS., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (the “Company”) (Nasdaq: DGLY), today announced that the Board of Directors (the “Board”) of the Company appointed D. Duke Daughtery...
Veterinary Diagnostics Market $7.27 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
11 oct. 2023 07h47 HE
|
The Insight Partners
Pune, India, Oct. 11, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Veterinary Diagnostics Market Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth...